Temefos (Diphos, Temephos) is an organophosphate larvicide, used to treat water infested with disease-carrying insects including mosquitoes, midges, and black fly larvae. Temefos affects the central nervous system through inhibition of cholinesterase, results in death before reaching the adult stage. Diphos has been used in trials studying the treatment of Plasmodium Falciparum Malaria. Temephos was first registered in the United States in 1965 by American Cyanamid Company for a number of uses including citrus fruits, pet collars, and mosquito control. A Registration Standard was issued in August, 1981. In response to EPA's 1991 Data Call-In, American Cyanamid dropped all uses except the mosquito larvicide use in non-potable waters and requested a low volume minor use waiver for relief from the data requirements associated with that use.

Triazamate (RH7988) is a fast-acting non-fumigant selective aphicide with contact and systemic action against a wide spectrum of aphid species. It is an inhibitor of cholinesterase. In European Union authorisations for plant protection products containing triazamate are withdrawn by 4 January 2006; no authorisations for plant protection products containing triazamate are granted or renewed from the date of publication.

Ethoprophos is a broad-spectrum nematicide and insecticide used pre-planting to control nematodes and soil dwelling insects. Research and testing has shown ethoprophos to offer effective control for soil nematodes and insects when used according to label guidelines. Ethoprophos is a cholinesterase inhibitor.

Bromopride is a dopamine D2 receptor blocker. Bromopride exerts is a gastrointestinal prokinetic exploited clinically for the management of motor disorders of the upper gastrointestinal tract, including functional dyspepsia, gastric stasis of various origins and emesis.

Bromopride is a dopamine D2 receptor blocker. Bromopride exerts is a gastrointestinal prokinetic exploited clinically for the management of motor disorders of the upper gastrointestinal tract, including functional dyspepsia, gastric stasis of various origins and emesis.